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3-Nitropropionic acid (3-NP) causes biochemical and morphological alterations in human and animal 
brain. Young adult male Wistar rats received 3-NP i. p. on five consecutive days and were investigated four 
weeks later (subacute treatment). Acute effects were investigated 24 h after one i. p. dose. Spontaneous 
or stimulus-evoked activity was recorded from cortical sensory foci, from subcortical nuclei and from the 
tail nerve, in urethane anesthesia. The subacutely treated rats were dissected and organ weights measured 
to study general toxic effects.
After subacute treatment, decrease was seen in the theta, and increase in the beta-2 and gamma, band 
of the spontaneous activity, dissimilarly in the cortical vs. subcortical sites. Latency of the sensory evoked 
potentials increased in all sensory foci after subacute treatment. Following acute treatment, amplitude 
of the somatosensory evoked potential decreased. The weight of the thymus decreased significantly in 
the treated rats.
Further studies could elucidate the link between biochemical effects of 3-NP and the observed functional 
neurotoxic changes.
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activity
The toxin 3-nitropropionic acid (3-NP) is naturally 
present in leguminous plants used to feed animals and 
can poison grazing livestock (1). Human poisoning 
may come from consumption of foodstuffs (sugar 
cane, cereals, etc.) infested with moulds of the 
Arthrinium and Aspergillus genus producing 3-NP.
Acute encephalopathy followed by dystonia can 
develop in humans exposed to low doses of 3-NP (2). 
Toxin-treated experimental animals showed decreased 
motor performance (3) with degeneration found 
primarily in the striatum, but also in the hippocampus 
and thalamus (4). The damage caused by 3-NP is used 
as animal model of Huntington’s disease (5, 6).
At the cellular level, 3-NP inhibits succinate 
dehydrogenase, a key enzyme of oxidative energy 
production (7), causing ATP levels in the brain to 
fall. This effect develops fast and is not limited to the 
sites of morphological damage (8). Since the function 
of the nervous system requires lots of energy, the 
mitochondrial damage is probably reflected in the 
electrical activity of the brain. Beyond that, 3-NP 
was found to act on N-methyl-D-aspartate (NMDA) 
receptors thereby inducing excitotoxicity (9) leading to 
further functional (and morphological) alterations. The 
measurement of these functional alterations could 
be convenient for following the development of the 
disease models (5,6), or for testing future drugs to be 
used in such models. The aim of this study was to test 
whether the applied neurophysiological methods were 
appropriate for the detection of functional neurotoxic 
changes caused by 3-NP in rats.
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METHODS
The effects of 3-NP were investigated in two 
different dosing regimens: subacute (the most 
frequently used scheme to model Huntington’s 
disease) and acute (to represent immediate effects). 
The subacute experiment included ten-week-old male 
Wistar rats (ten in a group), receiving 3-NP i. p. in the 
doses of 10 mg kg-1 b.w. (low dose) or 15 mg kg-1 
b.w. (high dose) for five consecutive days, and kept 
for four weeks before electrophysiological recording, 
similar to the experiment described by Beal et al. 
(10). The animals which received 3-NP i. p. as a single 
acute dose of 20 mg kg-1 were kept for 24 h before 
electrophysiological recording (4). Control animals 
were untreated.
For recording, the head of the animal - in urethane 
anaesthesia (1000 mg kg-1; cf. 11) - was fixed in 
a stereotaxic instrument. The skull was opened to 
expose the left hemisphere; wounds were sprayed 
with 10 % lidocaine, and the exposed cortex was 
covered with warm paraffin oil. After recovery from 
the surgery (30 min) silver electrodes were placed 
on the dura over the primary somatosensory (SS), 
visual (VIS) and auditory (AUD) areas (12). One steel 
needle electrode was inserted in the caudato-putamen 
(CAUD) and the globus pallidus (GPL; coordinates 
after Paxinos and Watson, 13). Spontaneous electrical 
activity (electrocorticogram, ECoG) was recorded 
from these sites simultaneously for six min, and the 
relative power spectrum of the frequency bands was 
determined by means of the Neurosys 1.11 software 
(Experimetria Ltd., UK).
Stimulus-evoked activity was then recorded via 
the same surface electrodes, and also from the tail 
nerve. Somatosensory stimulation was done using a 
pair of needles inserted into the whiskery part of the 
nasal skin, delivering rectangular electric stimuli (3 V 
to 4 V, 0.05 ms). Visual stimulation was performed 
by flashes (1 Hz, 60 lx) delivered by a flash generator 
via an optical fiber directly into the contralateral eye 
of the rat. For acoustic stimulation, sound clicks (1 
Hz, 40 dB), were applied into the ear of the rat. Fifty 
stimuli of each modality per rat were applied and the 
evoked activity recorded. After averaging, latency 
and duration of the evoked responses was measured 
manually. Evoked activity of the tail nerve was taken 
by inserting a stimulating and a recording electrode 
pair, and applying double stimuli (3 V to 4 V, 0.02 ms, 
1 ms to 10 ms inter-stimulus interval). From these 
data, conduction velocity (as described in reference 
14, but performed at room temperature), and relative 
and absolute refractory period (15) were calculated.
After recording, the subacutely treated rats 
were killed with an overdose of urethane, and then 
dissected. Organ weights were measured, and relative 
organ weights were calculated on the basis of the brain 
weight, as an index of general toxic effect. The results 
were tested for significance using the two-sample t-
test with p<0.05 or p<0.01 as a limit.
RESULTS
The most pronounced effect of subacute 3-NP 
treatment on the ECoG was the decrease in the 
theta activity seen in almost all cortical foci (Figure 
1). This was less obvious in acute treatment (Figure 
2). The increase in delta activity was significant only 
in the SS and CAUD area in subacute treatment, and 
in the SS and AUD area in acute treatment. In the 
alpha band, there was a massive decrease in the VIS 
area in both treated groups and, only in the acutely 
treated rats, also in the AUD area. In the fast bands 
(beta-1, beta-2, gamma) a significant increase was 
seen in the subacutely treated rats (SS, AUD, GPL) 
and a mild, but notable decrease in the acutely treated 
rats (AUD cortex).
The general slow-down of the cortical activity 
following subacute treatment with 3-NP was paralleled 
by the significant increase in the latency of sensory 
evoked potentials in all recorded cortical areas in both 
treated groups as opposed to control animals (Table 
1). The change seemed to be dose-dependent, but 
high vs. low dose differences were not significant. 
The change in the duration of responses was slight. 
In acute 3-NP exposure, there was no consequent 
effect on the latency: a small decrease in the SS 
and AUD response, but significant increase in the 
VIS response. In contrast, the duration of potentials 
significantly increased in the SS and VIS, but not in 
the AUD area.
The parameters of the tail nerve action potential 
had no uniform trend. The relative refractory periods 
showed a mild, but not significant increase. The 
absolute refractory period slightly increased after 
subacute treatment, but decreased after acute 
treatment. A clear decrease was seen, however, in the 
conduction velocity, with evident dose dependence in 
the subacutely treated rats.
Data obtained from dissection following subacute 
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treatment showed that 3-NP affected the main organs. 
The weights of organs decreased, except for the lung 
and the brain, but a significant decrease was only seen 
for the thymus (Table 2).
DISCUSSION
Rats treated with 3-NP showed a decrease in both 
spontaneous and stimulus-evoked cortical activity. 
By inhibiting mitochondrial oxidation, 3-NP depletes 
energy in the neurons, which results in a kind of tissue 
hypoxia. Similar effects were seen in volunteers exposed 
to low oxygen gas mixture, with the consequent shift 
of EEG toward lower frequencies (16). In humans with 
inherited or idiopathic mitochondrial dysfunction such 
as mitochondrial encephalomyopathy (ME), cortical 
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Figure 2  Relative power spectrum of the spontaneous cortical activity 
(somatosensory, visual, and auditory focus) in rats acutely 
treated with 3-NP: 20 mg kg-1. Ordinate: power spectrum of 
the standard ECoG bands (see insert in the uppermost panel 
for bar pattern). * p<0.05 vs. the same band in the control. 
(10 rats per group; 1 measurement per rat).
Figure 1  Relative power spectrum of the spontaneous cortical activity 
(somatosensory, visual, and auditory focus) and subcortical 
activity (caudato-putamen and globus pallidus) in rats, 
subacutely treated with 3-NP: 10 mg kg-1 (low dose) and 15 
mg kg-1 (high dose). Ordinate: power spectrum of the standard 
ECoG bands (see insert in the uppermost panel for bar pattern). 
* p<0.05 vs. the same band in the control. (10 rats per group; 
1 measurement per rat).
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functions are affected (17), which is manifest in slowed 
EEG activity (18) and in increased latency of certain 
visual evoked potential components (19, 20). In our 
study, subacute 3-NP administration, which impairs 
mitochondrial function, produced similar changes in 
the rats’ cortical activity. Based on these, the aim of the 
study was achieved; the applied neurophysiological 
methods were found appropriate for the detection of 
functional neurotoxic changes caused by 3-NP mainly 
in subacutely treated rats.
Another effect, inhibition of astrocytic glutamate 
uptake of 3-NP (21) could potentially lead to increased 
cortical excitatory transmission and to an increase 
in cortical evoked potentials by causing imbalance 
between excitation and inhibition. This effect, however, 
was not observed in our experiments, probably 
because it was suppressed by the general effect of 
mitochondrial dysfunction caused by 3-NP.
The significant decrease in thymus weight suggests 
that 3-NP may affect the immune system.
The overall effect of 3-NP on the cortical activity 
is complex, involving elements of depression and 
excitation. Further studies should elucidate which of 
the known effects of 3-NP is specifically responsible 
for the observed effects, and how these are related 
to biochemical and morphological changes known to 
be caused by 3-NP.
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Sažetak
DJELOVANJE 3-NITROPROPIONSKE KISELINE NA ŠTAKORE: OPÆA TOKSIÈNOST I 
FUNKCIJSKA NEUROTOKSIÈNOST
Toksin 3-nitropropionska kiselina (3-NP) uzrokuje biokemijske i morfološke promjene u mozgu. U 
istraživanju su mladi muški Wistar štakori intraperitonealno primali 3-NP pet dana uzastopce. Djelovanje 
toksina promatrano je èetiri tjedna kasnije (subakutna primjena). Akutni su uèinci promatrani 24 sata 
nakon intraperitonealne primjene. Spontana i podražajno izazvana aktivnost mjerena je na osjetilnim 
žarištima korteksa, na supkortikalnim jezgrama te na repnome živcu, dok su životinje bile pod uretanskom 
anestezijom.
Nakon subakutnoga doziranja zamijeæen je rast beta-2 i gama-valova kod spontane aktivnosti. Ova promjena 
nije bila istovjetna na kori i pod korom mozga. Stimulirana osjetilna aktivnost u ove je subakutne skupine 
pokazala poveæanu latenciju u svim osjetilnim podruèjima.
U štakora koji su primili jednokratnu akutnu dozu amplituda evociranoga somatosenzornoga potencijala 
bila je manja. Masa prsne žlijezde bila je znaèajno niža u štakora koji su primili 3-NP. Potrebna su 
daljnja istraživanja koja bi razjasnila povezanost izmeðu biokemijskoga djelovanja 3-NP-a i zamijeæenih 
neurotoksiènih funkcijskih promjena.
KLJUÈNE RIJEÈI: evocirani odgovor korteksa, potencijal živèanog djelovanja, spontana aktivnost 
korteksa
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